Published August 2008 | Version v1
Journal article

Therapeutic result of radioactive nuclide 90Sr/90Y treatment in patients with benign prostatic hypertrophy (BPH)

  • 1. Center of Radioimmunology, Haikou City People's Hospital, Affiliated Haikou Hospital, Xiangya Medical College of Central South University, Haikou (China)

Description

Objective: To study the effect of radioactive nuclide 90Sr/90Y treatment in patients with benign prostatic hypertrophy (BPH). Methods: Sixty patients with BPH were treated with a course of transurethral radioactive nuclide 90Sr/90Y therapy. Results: The severity of BPH was assessed with four parameters: maximal flow rate (MFR), volume of residual urine (VRU), international prostatic symptom score (IPSS) and volume (size) of prostate. In this series, the total effective rate was 93.33% with no treatment- related mortality. Favorable changes of the parameters after a course of radioactive nuclide therapy were significant. Conclusion: Radioactive nuclide 90Sr/90Y therapy for patients with BPH was safe, easily performed and quite effective. This procedure is worth popularizing in appropriate patients. (authors)

Additional details

Publishing Information

Journal Title
Journal of Radioimmunology
Journal Volume
21
Journal Issue
4
Journal Page Range
p. 310-312
ISSN
1008-9810

Optional Information

Notes
1 tab., 9 refs.